Cellectar Biosciences, Inc. Human Resources Contracts & Agreements
32 Contracts & Agreements
- Bonus & Incentive Agreements (17 contracts)
- Compensation Agreements (1)
- Consulting Agreements (1)
- Employment Agreements (13)
- Cellectar Biosciences, Inc. 2021 Stock Incentive Plan, as Amended (Filed With SEC on June 29, 2023)
- Amendment 1 to the 2021 Stock Incentive Plan (Filed With SEC on June 27, 2022)
- Employment Agreement between the Company and Chad Kolean, dated February 23, 2022 (Filed With SEC on February 25, 2022)
- 2021 Stock Incentive Plan (Filed With SEC on June 24, 2021)
- Employment Agreement between the Company and John Friend dated July 1, 2020 (Filed With SEC on July 1, 2020)
- Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on June 25, 2020)
- Amendment to Amended and Restated Employment Agreement between the Company and Jarrod Longcor, dated November 10, 2019 (Filed With SEC on November 12, 2019)
- Employment Agreement between the Company and Dov Elefant dated August 15, 2019 (Filed With SEC on August 15, 2019)
- Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on June 14, 2019)
- Amended and Restated Employment Agreement between the Company and Jarrod Longcor, dated April 15, 2019 (Filed With SEC on April 19, 2019)
- Amended and Restated Employment Agreement between the Company and James Caruso, dated April 15, 2019 (Filed With SEC on April 19, 2019)
- Employment Agreement between the Company and Brian Posner dated November 9, 2018 (Filed With SEC on November 13, 2018)
- Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on June 1, 2018)
- Employment Agreement between the Company and John E. Friend dated March 27, 2017 (Filed With SEC on November 9, 2017)
- Employment Agreement between the Company and Jarrod Longcor dated July 14, 2016 (Filed With SEC on November 9, 2017)
- RESTRICTED COMMON STOCK Granted by Cellectar Biosciences, Inc. (the“Company”) Under the 2015 Stock Incentive Plan (Filed With SEC on August 14, 2017)
- NON-STATUTORY STOCK OPTION Granted by Cellectar Biosciences, Inc.(the “Company”) Under the 2015 Stock Incentive Plan (Filed With SEC on August 12, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 12, 2015)
- Cellectar Biosciences, Inc. 2015 STOCK INCENTIVE PLAN (Filed With SEC on August 12, 2015)
- Novelos Therapeutics, Inc. AMENDED AND RESTATED 2006 STOCK INCENTIVE PLAN (Filed With SEC on December 18, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 13, 2013)
- CONSULTING AGREEMENT (Filed With SEC on November 13, 2013)
- THIRD AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on November 13, 2013)
- Novelos Therapeutics, Inc. AMENDED AND RESTATED 2006 STOCK INCENTIVE PLAN (Filed With SEC on October 26, 2012)
- SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on June 1, 2011)
- Novelos Therapeutics, Inc. AMENDED AND RESTATED 2006 STOCK INCENTIVE PLAN (Filed With SEC on May 23, 2011)
- (A) As compensation for the services provided by Rodman hereunder, the Company agrees to pay to Rodman a cash fee payable immediately upon the closing of the Placement equal to 8%... (Filed With SEC on June 25, 2010)
- Descriptionof Bonus Plan adopted on December8, 2009 (Filed With SEC on January 26, 2010)
- NovelosTherapeutics, Inc. 2006Stock Incentive Plan (asAmended November 3, 2009) (Filed With SEC on December 7, 2009)
- Form of Non-Statutory Director Stock Option under Novelos Therapeutics, Inc.s 2006 Stock Incentive Plan (Filed With SEC on December 15, 2006)
- Form of Non-Statutory Stock Option under Novelos Therapeutics, Inc.s 2006 Stock Incentive Plan (Filed With SEC on December 15, 2006)
- Form of Incentive Stock Option under Novelos Therapeutics, Inc.s 2006 Stock Incentive Plan (Filed With SEC on December 15, 2006)
